|By Marketwired .||
|November 13, 2013 11:00 AM EST||
HUNTSVILLE, AL -- (Marketwired) -- 11/13/13 -- Conversant Bio, a global leader in supplying the highest quality human tissue and viable cell samples, today announced it is issuing a new E-book focusing on the specific uses and importance of using blood samples in oncology research. The resource, The Definitive Guide to Oncology Blood Uses in Cancer Research, is available for free download on the company's website at: http://www.conversantbio.com/oncology-blood-for-cancer-research-ebook
Most of cancer research revolves around identifying and understanding the molecular and cellular makeup of cancer cells and how they behave differently from normal cells. High quality human biospecimens are an important part of this work. However, advancing cancer research not only requires tissues, but also biofluids such as blood.
In its newest E-book, Conversant Bio explains the five specific uses of blood in oncology research, and shares the key criteria researchers should look for when purchasing oncology blood for their studies. In addition, the E-book shares an overview of biomarker use in cancer medicine, dives into the use of biomarkers in drug development and uncovers the benefits of personalized medicine in cancer treatment.
"It's important for researchers to know that oncology blood opens up the possibility to advance their cancer research through sample specificity and flexibility," says Luke Dorion, Chief Commercial Officer for Conversant Bio. "Our goal with this E-book was to share crucial information about the uses and importance for oncology blood, so we can help scientists optimize their clinical trials and meet their cancer research goals."
For additional information about this new E-book or Conversant Bio's services, please visit the company's website at http://www.conversantbio.com/
About Conversant Bio
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S. based clinical sites, and an IRB reviewed chain of custody Quality Control System, Conversant Bio provides you with the highest quality samples on time, and on budget. For additional information about Conversant Bio's services, please visit the company's website at http://www.conversantbio.com/.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2456804
Chief Commercial Officer